Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McDermott

Showing results (91-100 of 666) with videos related to

Pageof 67
Sort By:
The American Journal of Orthopsychiatry|July 1, 1971
Abortion repeal in Hawaii: an unexpected crisis in patient careJ F McDermott, W F Char
Cancer|September 19, 2019
Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinomaCharlene M Mantia, David F McDermott
Journal of the American Academy of Child Psychiatry|September 1, 1984
Stage-related models of psychotherapy with childrenJ F McDermott, W F Char
Journal of Clinical Microbiology|April 12, 2003
Standardizing antimicrobial susceptibility testing of Campylobacter speciesPatrick F McDermott, Robert D Walker
BJU International|April 20, 2007
Immunotherapy for metastatic renal cell carcinomaDavid F McDermott, Brian I Rini
The American Journal of Psychiatry|April 3, 2018
Drs. McDermott and Putman ReplyJohn F McDermott, Patricia K Putman
Current Opinion in Molecular Therapeutics|January 27, 2009
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disordersLeigh D Church, Michael F McDermott
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Immunotherapy of metastatic renal cell carcinomaDavid F McDermott, Michael B Atkins
Clinical Genitourinary Cancer|August 21, 2009
The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinomaJessica M Clement, David F McDermott
Journal of the American Academy of Child Psychiatry|January 1, 1974
The undeclared war between child and family therapyJ F McDermott, W F Char
Pageof 67

Showing results (91-100 of 666) with videos related to

Sort By:
Pageof 67
The American Journal of Orthopsychiatry|July 1, 1971
Abortion repeal in Hawaii: an unexpected crisis in patient careJ F McDermott, W F Char
Cancer|September 19, 2019
Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinomaCharlene M Mantia, David F McDermott
Journal of the American Academy of Child Psychiatry|September 1, 1984
Stage-related models of psychotherapy with childrenJ F McDermott, W F Char
Journal of Clinical Microbiology|April 12, 2003
Standardizing antimicrobial susceptibility testing of Campylobacter speciesPatrick F McDermott, Robert D Walker
BJU International|April 20, 2007
Immunotherapy for metastatic renal cell carcinomaDavid F McDermott, Brian I Rini
The American Journal of Psychiatry|April 3, 2018
Drs. McDermott and Putman ReplyJohn F McDermott, Patricia K Putman
Current Opinion in Molecular Therapeutics|January 27, 2009
Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disordersLeigh D Church, Michael F McDermott
Cancer Journal (Sudbury, Mass.)|October 7, 2008
Immunotherapy of metastatic renal cell carcinomaDavid F McDermott, Michael B Atkins
Clinical Genitourinary Cancer|August 21, 2009
The high-dose aldesleukin (IL-2) "select" trial: a trial designed to prospectively validate predictive models of response to high-dose IL-2 treatment in patients with metastatic renal cell carcinomaJessica M Clement, David F McDermott
Journal of the American Academy of Child Psychiatry|January 1, 1974
The undeclared war between child and family therapyJ F McDermott, W F Char
Pageof 67